Lineage Cell Therapeutics (LCTX) Shareholding Patterns

$1.12

$-0.18 (-13.85%)

As on 26-Aug-2026 16:10EDT

Market cap

$278 Mln

Revenue (TTM)

$13 Mln

P/E Ratio

--

P/B Ratio

4.6

Div. Yield

0 %

Annual
Quarterly